Skip to main content
HRTX $0.34 +0.69%
HRTX logo

HRTX · Heron Therapeutics, Inc. /De/

Track HRTX — free
$0.34 +0.00 (+0.69%) At close · Aug 14
Market Cap
$63.92M
Shares
189.85M
All earnings calls

Earnings call · FY2026 Q2

Heron Therapeutics Q2 2026 Conference Call

Heron Therapeutics Q2 2026 Conference Call

Concluded Aug 10, 2026
Aug 10, 2026 0 turns
Period
FY2026 Q2
Runtime
Sources
2 artifacts

Executive readout · one minute

Call research workspace

Read the call alongside every captured source. Audio, transcript, slides and SEC filings stay in one workspace.

Research coverage

2 live sources

Switch sources without leaving this page or losing your listening position.

Revenue $37.67M +1.3% YoY
Diluted EPS -$0.03
Gross margin 69.3% -4.2 pp YoY
Net income -$5.49M

Research materials

Open the source you need; every reader stays inside this workspace.

Quarter detail

How the reported period landed and where the business moved.

Revenue · products & services

CINVANTI$21.79M -9.7% YoY
ZYNRELEF$11.06M +35% YoY
Aponvie$4.28M +73.6% YoY
SUSTOL$540,000 -77.5% YoY
Full-screen source Call document